4//SEC Filing
Bonner Michael 4
Accession 0001209191-18-021463
CIK 0001087294other
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 5:40 PM ET
Size
7.8 KB
Accession
0001209191-18-021463
Insider Transaction Report
Form 4
Bonner Michael
Chief Financial Officer
Transactions
- Purchase
Common Stock
2018-03-19$6.72/sh+300$2,016→ 15,997 total - Tax Payment
Common Stock
2018-03-23$6.70/sh−843$5,648→ 17,654 total - Award
Common Stock
2018-03-23$6.70/sh+2,500$16,750→ 18,497 total
Footnotes (2)
- [F1]Restricted stock award will vest 100% on March 20, 2022.
- [F2]This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.
Documents
Issuer
CUMBERLAND PHARMACEUTICALS INC
CIK 0001087294
Entity typeother
Related Parties
1- filerCIK 0001666790
Filing Metadata
- Form type
- 4
- Filed
- Mar 22, 8:00 PM ET
- Accepted
- Mar 23, 5:40 PM ET
- Size
- 7.8 KB